Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

The DHT immunoassay is unreliable due to high cross-reactivity with testosterone.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Dermoscopy is becoming essential for diagnosing skin conditions and is expected to be a standard tool for dermatologists.

TrichoScan offers a painless way to analyze and manage hair loss.

Exosome treatments may cause mild inflammation, new blood vessel growth, and hair growth, detectable by ultrasound.

Higher BMI, IGF-1, and DHEAS levels are linked to advanced bone age in young Chinese girls with early breast development.

Hair cortisol levels can show increased stress during late pregnancy but only for up to six months.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Finasteride improves hair loss in women with hyperandrogenism.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Treatments for melanin disorders exist, but more effective options needed.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

3D-printed microneedles improve drug delivery by being precise, cost-effective, and less invasive.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.